This week’s RGH Pharmacy
E-Bulletin gives an update
on the use of varenicline and
neuropsychiatric adverse effects
(AEs), citing recent reviews which
clarified that even patients with
pre-existing psychiatric conditions,
do not appear to be at increased
risk of neuropsychiatric AEs when
attempting smoking cessation
aided by the use of varenicline.
CLICK HERE for the e-bulletin.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Sep 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.